Hypertension

Latest News

Elevated Arterial Stiffness: A Strong, Independent Predictor of Diabetes

A study was conducted to determine if, compared with hypertension, arterial stiffness is a more accurate predictor of diabetes risk.

Aprocitentan Significantly Reduces BP in Patients With Resistant Hypertension

The PRECISION study included adults with uncontrolled blood pressure despite at least 3 background antihypertensive medications.

Pregnancy-Induced Hypertensive Disorders and Cholesterol Crystals in Maternal Decidua Tissue

Researchers examined if post-delivery decidual tissue contained cholesterol crystals in patients that developed a hypertensive disorder during pregnancy.

Hypertension, Arterial Stiffness Linked to Risk for Diabetes

Hypertension and arterial stiffness (AS) are associated with the risk for diabetes, with the highest risk seen for those with both hypertension and AS.

Asymptomatic Peripheral Artery Disease and Increased Risk for Mortality, CV Outcomes

A study was conducted to examine the risk for adverse cardiovascular events in patients with asymptomatic peripheral arterial disease and various CV risk factors.

Accupril Tablets Recalled Due to Nitrosamine Impurity

Nitrosamine impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.

Hypertensive Disorders of Pregnancy Prevalence Up From 2017 to 2019

During 2017 to 2019, there was an increase in the prevalence of hypertensive disorders of pregnancy (HDP) among delivery hospitalizations.

Hypertensive Disorders of Pregnancy Tied to Increased CVD Risk Later in Life

Women with hypertensive disorders of pregnancy (HDP) have an increased risk for cardiovascular disease (CVD) later in life, with most of the increased risk conferred by established CVD risk factors.

Healthy Lifestyle May Attenuate Diabetes-Associated Risk for Hypertension

A population-based, cross-sectional study was conducted to evaluate the effect of lifestyle on the risk for hypertension in patients with diabetes.

Ampreloxetine Misses Endpoint in Second Neurogenic Orthostatic Hypotension Trial

The phase 3 REDWOOD study included patients aged 30 years and older with primary autonomic failures and symptomatic neurogenic orthostatic hypotension.